Amgen Ventures
Corporate VCThousand Oaks · Seed–Late Stage
Investment thesis
Amgen pursues innovative approaches to drug discovery and development by leveraging artificial intelligence, generative biology, and human genetic data to create precision medicines for serious illnesses. The company focuses on four therapeutic areas—general medicine, rare disease, inflammation, and oncology—with an emphasis on reliability, safety, and responsible operations across its global supply chain.
Source: firm website, verified Jul 21, 2026.
Frequently asked questions
- What stage does Amgen Ventures invest at?
- Amgen Ventures invests at the Seed, Late Stage stages.
- What sectors does Amgen Ventures focus on?
- Amgen Ventures focuses on Biotech.
- Where is Amgen Ventures located?
- Amgen Ventures is headquartered in Thousand Oaks, US.
Images
Similar investors
a16z is a venture capital firm founded in 2009 by Marc Andreessen and Ben Horowitz that invests in seed through growth-stage technology companies across multiple sectors including AI, healthcare, consumer, crypto, enterprise, fintech, and gaming. The firm manages over $100 billion in assets and operates a distinctive platform model with a large team of operators supporting founders throughout their journey.
B Capital is a venture capital firm managing over $12 billion in assets with a stage-based fund approach. The firm invests across early to late-stage companies in technology, healthcare, and energy & resilience sectors, with 200+ portfolio companies and 9 global offices.
Bessemer Venture Partners is a venture capital firm with a 50-year history supporting entrepreneurs in building enduring companies globally. The firm draws on deep operational expertise and advisory relationships to support portfolio companies through their growth journey.
DCVC is a deep tech venture capital firm with over a dozen years of experience backing entrepreneurs using computational approaches to solve trillion-dollar problems across industries including AI, climate, materials science, robotics, space, and biology.
GV is Alphabet's venture capital arm, established in 2009 as Google Ventures. Operating with long time horizons and over $13 billion in assets under management, the firm invests across technology and life sciences sectors from seed to growth stages, supporting 400 active portfolio companies across North America, Europe, and Israel.